Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Clinical trial NCT04552769 · COMPLETED
Trial details
- NCT number
- NCT04552769
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2023-04-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.